MRK
Merck & Co., Inc.NYSEHealthcare$120.87+0.02%OpenMarket Cap: $298.84B
As of 2026-04-06
Valuation
P/E (TTM)
16.37
PEG
2.46
P/B
5.72
P/S
4.60
EV/EBITDA
12.73
DCF Value
$158.58
FCF Yield
4.1%
Div Yield
2.7%
Margins & Returns
Gross Margin
81.5%
Operating Margin
41.2%
Net Margin
28.1%
ROE
36.2%
ROA
20.6%
ROIC
20.8%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $16.40B | 92.7% | $8.74B | $2.96B | $1.19 | $0.85 |
| FY 2025 | $65.01B | 81.5% | $26.78B | $18.25B | $7.28 | $3.28 |
| Q3 2025 | $17.28B | 77.7% | $6.55B | $5.79B | $2.32 | $0.81 |
| Q2 2025 | $15.81B | 77.5% | $5.55B | $4.43B | $1.76 | $0.81 |
| Q1 2025 | $15.53B | 78.0% | $5.94B | $5.08B | $2.01 | $0.81 |
| Q4 2024 | $15.62B | 75.5% | $4.35B | $3.74B | $1.48 | $0.81 |
| FY 2024 | $64.17B | 76.3% | $20.22B | $17.12B | $6.74 | $3.12 |
| Q3 2024 | $16.66B | 75.5% | $3.98B | $3.16B | $1.24 | $0.77 |
| Q2 2024 | $16.11B | 76.8% | $6.13B | $5.46B | $2.14 | $0.77 |
| Q1 2024 | $15.78B | 77.6% | $5.76B | $4.76B | $1.87 | $0.77 |
| Q4 2023 | $14.63B | 73.3% | $-1.71B | $-1.23B | $-0.48 | $0.77 |
| FY 2023 | $60.12B | 73.2% | $2.95B | $365.0M | $0.14 | $2.96 |